3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
64
Head and Neck Neoplasms
63
Squamous Cell Carcinoma of Head and Neck
60
Carcinoma, Non-Small-Cell Lung
34
Rectal Neoplasms
23
Colonic Neoplasms
23
Neoplasm Metastasis
19
Neoplasms
18
Carcinoma, Squamous Cell
17
Pancreatic Neoplasms
13
Lung Neoplasms
13
Esophageal Neoplasms
11
Tongue Neoplasms
9
Stomach Neoplasms
9
Recurrence
9
Carcinoma
8
Neoplasms, Squamous Cell
6
Mouth Neoplasms
6
Laryngeal Neoplasms
6
Breast Neoplasms
6
Adenocarcinoma Of Esophagus
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Esophageal Squamous Cell Carcinoma
5
Adenocarcinoma of Lung
5
Sarcoma
4
Salivary Gland Neoplasms
4
Oropharyngeal Neoplasms
4
Laryngeal Diseases
4
Precancerous Conditions
3
Hypopharyngeal Neoplasms
3
Interventions
Paclitaxel
6
Carboplatin
6
Gemcitabine
3
pembrolizumab
2
Irinotecan
2
Erlotinib Hydrochloride
2
Capecitabine
2
Bevacizumab
2
sintilimab
1
pertuzumab
1
pemigatinib
1
olaparib
1
ivosidenib
1
ipatasertib
1
etoposide phosphate
1
erythromycin propionate-N-acetylcysteinate
1
entrectinib
1
cobimetinib
1
belinostat
1
atezolizumab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
alectinib
1
Vemurafenib
1
Surveys and Questionnaires
1
Oxaliplatin
1
HhAntag691
1
Everolimus
1
Etoposide
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Unknown Primary
×
Cetuximab
×
Clear all
No trials found.